More about
Refractory And Fulminant Infections
News
November 04, 2024
2 min read
Save
‘Some may die’: AGA urges continued access to conventional FMT for C. difficile patients
OpenBiome will continue distribution of investigational fecal microbiota transplantation through 2024, as suspension may put certain patients with recurrent, refractory or fulminant Clostridioides difficile at risk, according to the AGA.